Study guide
9.1 Oral Appliance Therapy: Indications, Candidacy & Side Effects
Certification in Clinical Sleep Health CCSH
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Sleep Physiology
1.1 CCSH Exam Overview & Clinical Scope 1.2 Sleep Architecture, Stages & Normal Cycles 1.3 Neurobiology & The Two-Process Model of Sleep
2 Chapter 2: Circadian Biology, Lifespan & Normal Variation
2.1 Circadian Biology & Melatonin Regulation 2.2 Sleep Across the Lifespan: Pediatric to Geriatric 2.3 Sex, Gender, Environment & Culture: Variations in Normal Sleep
3 Chapter 3: Abnormal Sleep: Classification, Prevalence & Consequences
3.1 Classification, Terminology, Prevalence & Acute vs. Chronic Sleep Disturbances 3.2 Short- and Long-Term Effects of Sleep Disruption, Deprivation & Restriction
4 Chapter 4: Comorbid Medical & Mental Health Conditions
4.1 Cardiopulmonary, Metabolic & Neurological Comorbidities 4.2 Mental Health Disorders, Substance Use & Sleep 4.3 Chronic Pain & Other Medical Conditions Affecting Sleep
5 Chapter 5: Clinical Assessment, Documentation & Medications
5.1 Validated Questionnaires & Screening Instruments 5.2 Comprehensive Sleep History & Physical Assessment 5.3 Quality of Life, Health Changes & Clinical Documentation 5.4 Medications, OTC Products, Supplements & Substances: Effects on Sleep
6 Chapter 6: Sleep Testing & Explaining Results
6.1 Diagnostic Sleep Testing Modalities 6.2 Split-Night and Titration Studies, PAP-NAP, Oximetry & Explaining Results
7 Chapter 7: Sleep-Related Breathing Disorders
7.1 Obstructive Sleep Apnea: Pathophysiology & Diagnosis 7.2 Central Sleep Apnea, Cheyne-Stokes & Emergent Apneas 7.3 Sleep-Related Hypoventilation & Obesity Hypoventilation Syndrome
8 Chapter 8: Positive Airway Pressure Therapy & Titration
8.1 Modes of PAP Therapy: CPAP, APAP, BiPAP & ASV 8.2 Interfaces, Humidification & Equipment Troubleshooting 8.3 Objective PAP Adherence Monitoring & Troubleshooting
9 Chapter 9: Non-PAP Treatments for Sleep Apnea
9.1 Oral Appliance Therapy: Indications, Candidacy & Side Effects 9.2 Surgical Interventions & Hypoglossal Nerve Stimulation 9.3 Positional Therapy & Lifestyle Modifications
10 Chapter 10: Insomnia & Circadian Rhythm Sleep-Wake Disorders
10.1 Chronic Insomnia: ICSD-3 Classification & Assessment 10.2 Cognitive Behavioral Therapy for Insomnia (CBT-I) Principles 10.3 Circadian Rhythm Sleep-Wake Disorders & Light Therapy
11 Chapter 11: Hypersomnias, Parasomnias & Movement Disorders
11.1 Central Disorders of Hypersomnolence 11.2 Parasomnias: NREM & REM Sleep Behavior Disorders 11.3 Sleep-Related Movement Disorders: RLS & PLMD
12 Chapter 12: Patient, Family & Community Education
12.1 Health Literacy, Plain Language & Teach-Back 12.2 Cultural Competency, Diversity of the Learner & Language Access 12.3 Readiness to Learn & Teaching Across Age, Development and Role 12.4 Learning Styles, Adult Learning Principles & Teaching Methods 12.5 Communication Barriers, Disabilities & Educating Families, Professionals and the Community
13 Chapter 13: Self-Management & Behavior Change
13.1 Motivational Interviewing & Overcoming Treatment Barriers 13.2 Sleep Hygiene Education Across Lifestyles and Settings 13.3 Self-Assessment & Self-Management Tools 13.4 Commercial Drivers, Transportation Regulations & Drowsy Driving
14 Chapter 14: Care Coordination, Guidelines, Telehealth & Ethics
14.1 Interdisciplinary Care Coordination & Patient Navigation 14.2 Chronic Disease Model, Care Plans & AASM Clinical Practice Guidelines 14.3 Telehealth Modalities & Remote Patient Monitoring 14.4 Ethics, Scope of Practice & Legal Standards
15 Chapter 15: Program Administration, Public Health & Safety
15.1 Building Collaborative Sleep Programs: Perioperative, Occupational, Outpatient & Support Models 15.2 Quality Improvement, Clinical Outcomes & Accreditation Standards 15.3 Sleep as a Public Health Issue: Community Outreach & Public Policy 15.4 Clinical Safety, Infection Control & Emergency Protocols
9.1 Oral Appliance Therapy: Indications, Candidacy & Side Effects
Key Takeaways Explain This Topic AI
Mandibular advancement devices (MAD) mechanically protrude the mandible and attached suprahyoid structures to widen the retroglossal airway and reduce pharyngeal collapsibility, whereas tongue-retaining devices (TRD) stabilize the tongue via negative suction in edentulous patients.
The 2015 AASM/AADSM guideline says sleep physicians should consider a custom, titratable oral appliance for adults with OSA who are intolerant of CPAP or prefer alternate therapy, and should prescribe one for primary snoring when treatment is requested.
A qualified dentist assesses candidacy: enough healthy, well-supported teeth to anchor the device (often about 8–10 per arch), healthy periodontium, adequate protrusion and no significant TMJ disease; titration usually starts at about 50–70% of maximum protrusion.
Short-term side effects include transient hypersalivation, morning dry mouth, and jaw stiffness, whereas long-term irreversible risks involve dental occlusal changes, lingual tipping of maxillary incisors, mesial movement of mandibular molars, and decreased overjet and overbite.
Subjective symptom resolution is an unreliable indicator of therapeutic success; follow-up objective sleep testing (PSG or HSAT) with the oral appliance titrated and in place is clinically required to verify adequate AHI reduction.
Last updated: October 2026
9.1 Oral Appliance Therapy: Indications, Candidacy & Side Effects
Quick Answer: Oral Appliance Therapy (OAT) is an established non-PAP treatment for obstructive sleep apnea (OSA). Mandibular Advancement Devices (MAD) mechanically advance the mandible and attached suprahyoid structures anteriorly to enlarge the retroglossal airway and reduce pharyngeal collapsibility (lowering critical closing pressure, Pcrit). Tongue Retaining Devices (TRD) utilize negative suction to secure the tongue forward, serving edentulous patients. Under the 2015 joint AASM/AADSM guideline, sleep physicians should consider a custom, titratable oral appliance, rather than no treatment, for adults with OSA who cannot tolerate CPAP or prefer an alternative. Candidacy requires evaluation by a qualified dentist, enough healthy teeth to anchor the device (often cited as about 8–10 per arch) and adequate jaw protrusion (typically 8–12 mm). Follow-up objective sleep testing (PSG or HSAT) with the appliance in place is mandatory because subjective symptom resolution does not reliably guarantee objective AHI control.
While Continuous Positive Airway Pressure (CPAP) remains the primary treatment for obstructive sleep apnea across all severity categories, real-world effectiveness is frequently hindered by non-adherence. Oral appliances provide a clinically validated alternative that expands upper airway caliber through mechanical repositioning of craniofacial tissues.
Biomechanical Mechanisms of Action
Pharyngeal collapse during sleep occurs when negative intraluminal inspiratory pressure exceeds pharyngeal dilator muscle tone. Oral appliances modify upper airway anatomy through two distinct biomechanical mechanisms:
1. Mandibular Advancement Devices (MAD / MAS)
Mandibular advancement devices (also termed mandibular advancement splints) are custom-fabricated, dual-arch appliances that fit over the maxillary and mandibular dentition:
Retroglossal Airway Expansion: Forward translation of the mandible exerts anterior traction on the attached genioglossus, geniohyoid, and mylohyoid muscles, pulling the tongue base away from the posterior pharyngeal wall.
Retropalatal Stabilization: Forward mandibular displacement indirectly tensions the palatoglossus muscle and soft palate, increasing the anteroposterior diameter of the velopharynx.
Lateral Wall Stiffening: Inferior and anterior displacement stretches the stylopharyngeus and palatopharyngeus muscles, stabilizing the lateral pharyngeal walls against dynamic collapse.
Pcrit Reduction: By mechanically pre-tensioning pharyngeal tissues, MADs shift the pharyngeal critical closing pressure (Pcrit) toward more negative pressures, preventing inspiratory airway collapse.
Custom vs. Non-Custom Appliances: AASM/AADSM clinical guidelines specify that patients should receive custom-fabricated, adjustable appliances rather than non-custom, over-the-counter ("boil-and-bite") devices. Over-the-counter appliances demonstrate poor retention, high discontinuation rates, cannot be titrated, and exert erratic orthodontic forces that cause rapid, adverse dental shifts.
2. Tongue Retaining Devices (TRD)
Tongue retaining devices feature a custom or prefabricated silicone bulb that rests between the lips and anterior teeth:
Mechanism: The patient inserts the tongue into the bulb and creates negative suction. The bulb holds the tongue forward throughout sleep without requiring mandibular advancement.
Indications: TRDs are indicated primarily for edentulous patients, individuals with severe periodontal disease lacking sufficient anchoring teeth for a MAD, or patients with severe temporomandibular joint (TMJ) arthropathy that prohibits mandibular protrusion.
Limitations: TRDs are generally less accepted than MADs due to tongue discomfort, mucosal irritation, nocturnal salivary pooling, and frequent dislodgement during sleep.
Clinical Indications & AASM/AADSM Guidelines
Joint clinical practice guidelines from the American Academy of Sleep Medicine (AASM) and American Academy of Dental Sleep Medicine (AADSM) outline clear evidence-based indications for oral appliance therapy:
The current joint guideline (Ramar and colleagues, 2015) makes these main recommendations:
Primary snoring: sleep physicians should prescribe oral appliances, rather than no therapy, for adults who request treatment of primary snoring without OSA (standard).
Custom, titratable devices: when oral appliance therapy is prescribed, a qualified dentist should use a custom, titratable appliance rather than a non-custom device (guideline).
OSA: sleep physicians should consider oral appliances, rather than no treatment, for adults with OSA who are intolerant of CPAP or prefer alternate therapy (standard).
Dental oversight: a qualified dentist should provide follow-up to watch for dental side effects and occlusal changes (guideline).
Follow-up testing: sleep physicians should arrange follow-up sleep testing to improve or confirm treatment efficacy (guideline), and both the physician and dentist should see the patient periodically.
The older AASM practice parameters (2006) framed oral appliances as appropriate for mild-to-moderate OSA in patients who prefer them or fail CPAP, and advised a CPAP trial first in severe OSA. CPAP remains the most effective therapy for severe OSA, so a patient with severe OSA who chooses an oral appliance needs especially careful objective follow-up.
Important
A physician must always confirm the formal diagnosis of obstructive sleep apnea before oral appliance fabrication. The sleep physician issues the prescription for OAT, refers the patient to a qualified sleep dentist, and remains responsible for ordering follow-up objective diagnostic testing.
Candidacy Assessment & Dental Evaluation
Successful oral appliance therapy requires close multidisciplinary collaboration between the sleep physician, the clinical sleep health specialist (CCSH), and a qualified sleep dentist (a dentist who is a Diplomate of the American Board of Dental Sleep Medicine [ABDSM] or holds accredited training). Pre-treatment dental evaluation assesses several anatomical and functional parameters:
Dentition & Periodontal Requirements
To withstand reciprocal anchoring forces without tooth loosening or periodontal breakdown, patients must meet strict dental criteria:
Sound Tooth Count: A commonly cited rule of thumb is about 8 to 10 healthy teeth per arch ; the dentist judges whether the remaining teeth can anchor the device.
Periodontal Health: Active, untreated periodontitis, alveolar bone loss exceeding 50%, or Grade II/III tooth mobility represent strict contraindications to MAD therapy until periodontally stabilized.
Crown Morphology: Retentive anatomical crowns or stable restorations are required to keep the appliance seated securely during sleep.
Temporomandibular Joint (TMJ) & Protrusion Screening
The qualified sleep dentist examines masticatory muscles, TMJ range of motion, and maximum voluntary protrusion using a precision gauge:
Maximum Voluntary Protrusion: Baseline physiological mandibular protrusion typically ranges from 8 to 12 mm .
Titration Starting Point: The initial construction bite is typically set at 50% to 70% of maximum voluntary protrusion (e.g., 5 to 7 mm forward in a patient with 10 mm maximum protrusion) with 2 to 5 mm of interincisal vertical opening.
Incremental Advancement: The appliance is advanced incrementally (typically 0.25 to 0.5 mm every 1 to 2 weeks) based on clinical symptom improvement, snoring reduction, and jaw comfort.
Contraindications: Severe active TMJ arthralgia, painful internal disc derangement without reduction, advanced fibrous or bony ankylosis, or severe limitation of opening (less than 25 mm) contraindicate MAD placement.
Side Effects & Clinical Management
Adverse effects of oral appliance therapy are classified as short-term transient symptoms or long-term irreversible structural changes:
Short-Term Side Effects
Short-term side effects typically arise during the initial acclimation and titration phases and resolve with consistent use or minor adjustments:
Excessive Salivation (Hypersalivation): Foreign body stimulation in the oral cavity stimulates salivary flow; typically resolves within 2 to 4 weeks.
Morning Xerostomia (Dry Mouth): Lip incompetence or mouth breathing around the device causes oral mucosal dehydration.
Transient Tooth Tenderness: Localized pressure on anchoring teeth upon morning removal, generally lasting 15 to 60 minutes.
Masticatory Muscle Fatigue & Jaw Stiffness: Transient soreness in the masseter, temporalis, and lateral pterygoid muscles upon waking.
Management: Instruct patients in morning repositioning exercises and provide a morning alignment jig (bite wafer). Chewing a morning wafer for 5 to 10 minutes helps re-engage centric occlusion and repositions the condyles within the glenoid fossae.
Long-Term Irreversible Sequelae
Persistent nocturnal forward traction over months and years creates reciprocal orthodontic forces that alter tooth positions and occlusal contact:
Dental Occlusal Changes: Mesial movement of mandibular molars and distal tipping of maxillary molars.
Incisor Tipping: Lingual tipping (retroclination) of maxillary incisors and labial tipping (proclination) of mandibular incisors.
Decreased Overjet and Overbite: Progressive reduction in horizontal overlap (overjet) and vertical overlap (overbite), occasionally resulting in an anterior edge-to-edge relationship or anterior crossbite.
Posterior Open Bite: Loss of bilateral occlusal contact in the molar and premolar regions.
Management: Dental follow-up is commonly scheduled every 6 months during the first year and at least yearly thereafter, as the 2015 guideline advises ongoing dental oversight. Sleep dentists take baseline study models or digital 3D intraoral scans to track subclinical dental movements.
Verification of Efficacy & Follow-Up Protocols
A critical responsibility of the Clinical Sleep Health Specialist (CCSH) is educating patients that subjective symptom relief does not equal objective physiological control:
The Clinical Trap of Subjective Improvement: Patients often report complete elimination of snoring and marked improvement in daytime alertness despite having a persistently elevated residual AHI.
Mandatory Objective Sleep Testing: Once the qualified sleep dentist achieves optimal clinical titration, a follow-up objective sleep study (in-laboratory polysomnography or home sleep apnea testing) must be conducted with the oral appliance titrated and worn in place to objectively quantify residual AHI, respiratory disturbance index (RDI), and oxygen desaturation.
Treatment Success Criteria: Complete response is defined as a reduction in AHI to less than 5 events/hour. A partial response is defined as an AHI reduction ≥ 50 % \ge 50\% ≥ 50% from baseline with residual AHI less than 10 events/hour. If residual AHI remains elevated, further dental advancement or transition/combination with PAP therapy is warranted.
Comparison: MAD vs. TRD vs. CPAP
Clinical Parameter Mandibular Advancement Device (MAD) Tongue Retaining Device (TRD) Continuous Positive Airway Pressure (CPAP)
Primary Mechanism Mechanical forward and downward displacement of mandible and suprahyoid muscles Negative suction bulb holds tongue body anteriorly between lips and teeth Pneumatic splinting of pharyngeal airway via pressurized air column
AHI Reduction Efficacy Moderate to High (typically 50–70% AHI reduction; highly effective in mild-moderate OSA) Moderate (variable AHI reduction, generally lower than custom MAD) High (90–100% resolution of obstructive events when worn)
Long-Term Adherence Often good; many patients prefer it to CPAP, and some devices record objective wear time Low to Moderate (limited by tongue soreness, mucosal irritation, and dislodgement) Variable to Moderate (CMS adherence threshold ≥ 4 \ge 4 ≥ 4 hr/night on 70% of nights met by ~50–65%)
Comfort & Portability Excellent; compact, noiseless, highly portable, requires no electrical power Good portability; noiseless, but higher intraoral discomfort Moderate; requires motor, mask interface, hose, power source, and water chamber
Dentition Requirements Enough healthy teeth to anchor the device (often about 8–10 per arch) and healthy periodontal support Minimal (suitable for fully edentulous arches or severe periodontal compromise) None (no dentition or TMJ structural requirements)
Contraindications Severe TMJ arthritis, active periodontitis, mobile teeth, protrusion less than 5 mm Severe nasal obstruction, inability to breathe nasally, macroglossia preventing suction Severe bullous lung disease, recurrent CSF leaks, facial trauma (relative)
Long-Term Complications Occlusal bite changes, decreased overjet/overbite, incisor tipping, posterior open bite Salivary pooling, transient lingual paresthesia, dorsal tongue mucosal ulceration Aerophagia, facial skin breakdown, interface pressure leaks, nasal mucosal drying